High Chromosome Number in hematological cancer cell lines is a Negative Predictor of Response to the inhibition of Aurora B and C by GSK1070916
<p>Abstract</p> <p>Background</p> <p>Aurora kinases play critical roles in mitosis and are being evaluated as therapeutic targets in cancer. GSK1070916 is a potent, selective, ATP competitive inhibitor of Aurora kinase B and C. Translation of predictive biomarkers to th...
Main Authors: | Hardwicke Mary, Bachman Kurtis, Jing Junping, Greshock Joel, Plant Ramona, Oleykowski Catherine A, Moy Christopher, Wooster Richard, Degenhardt Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/9/1/110 |
Similar Items
-
Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells
by: Zhuo-Xun Wu, et al.
Published: (2021-01-01) -
3D-QSAR and Molecular Docking Studies on Derivatives of MK-0457, GSK1070916 and SNS-314 as Inhibitors against Aurora B Kinase
by: Chunzhi Ai, et al.
Published: (2010-11-01) -
Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells
by: Zhuo-Xun Wu, et al.
Published: (2021-04-01) -
GSK-3 inhibitors induce chromosome instability
by: Staples Oliver D, et al.
Published: (2007-08-01) -
Combined Phosphatase and Tensin Homolog (PTEN) Loss and Fatty Acid Synthase (FAS) Overexpression Worsens the Prognosis of Chinese Patients with Hepatocellular Carcinoma
by: Xuehua Zhu, et al.
Published: (2012-08-01)